menu ☰
menu ˟

Effectiveness of injectable extended-release naltrexone vs daily buprenorphineâ?"naloxone for opioid dependence: A randomized clinical noninferiority trial.

Creator:

Drug and Alcohol Findings

Type: Article
Region: Republic of Ireland
Northern Ireland
Description:

Key points from summary and commentary A novel study testing the relative effectiveness of injections of extended-release naltrexone and a daily combination of oral buprenorphine hydrochloride and naloxone hydrochloride for maintaining abstinence from heroin and other opioids. Treatment with extended-release naltrexone was found no less effective than buprenorphineâ?"naloxone in terms of retaining patients in treatment, reducing the number of days of injecting and craving for opioids, and reducing the use of heroin, and other illicit drugs. The authors concluded that maintaining short-term abstinence with extended-release naltrexone should be considered an â?oequalâ? medication-assisted treatment alternative to buprenorphine-naloxone for opioid-dependent individuals

Date:

01/02/2018

Rights: Public
Suggested citation:

Drug and Alcohol Findings. (2018) Effectiveness of injectable extended-release naltrexone vs daily buprenorphineâ?"naloxone for opioid dependence: A randomized clinical noninferiority trial. [Online]. Available from: http://publichealthwell.ie/node/1146343 [Accessed: 22nd May 2019].

  

View your saved citations and reading lists

Contributor:

National Drugs Library
 
Click here to view all the resources gathered from this organisation's website.